SCHEMBL2225876

SCHEMBL2225876

NS(=O)(=O)c1ccc(OCC(F)(F)F)c(CNc2cc(Nc3ccc(Cl)cn3)ncn2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 6/20 0.63
TNNI3K Q59H18 6/20 0.51
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 1/20 0.41
EGFR P00533 2/20 0.41
MAPT P10636 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
STAT3 P40763 1/20 0.40
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38
MAPK10 P53779 1/20 0.37
ABL1 P00519 1/20 0.36
BCR P11274 1/20 0.36
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
CCNA2 P20248 1/20 0.36
CCNE1 P24864 1/20 0.36
CDK2 P24941 1/20 0.36
CDK5 Q00535 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2225786 0.90 BRAF (0.50) BRAFTNNI3KLMNASMN1; SMN2ALDH1A1
SCHEMBL2227178 0.90 TNNI3K (0.61) BRAFTNNI3KLMNASMN1; SMN2ALDH1A1
SCHEMBL2228424 0.89 TNNI3K (0.61) BRAFTNNI3KLMNASMN1; SMN2ALDH1A1
SCHEMBL2226948 0.88 BRAF (0.48) BRAFTNNI3KALDH1A1EGFRKDM4E
SCHEMBL2225756 0.87 BRAF (0.62) BRAFTNNI3KLMNASMN1; SMN2ALDH1A1
SCHEMBL2227987 0.87 BRAF (0.49) BRAFTNNI3KLMNAEGFRKDM4E
SCHEMBL2226387 0.86 BRAF (0.51) BRAFTNNI3KLMNASMN1; SMN2ALDH1A1
SCHEMBL2226257 0.83 TNNI3K (0.49) BRAFTNNI3KLMNASMN1; SMN2ALDH1A1
SCHEMBL2226261 0.81 TNNI3K (0.58) BRAFTNNI3KEGFRMAPK10CDK1
SCHEMBL2224948 0.80 TNNI3K (0.51) BRAFTNNI3KLMNASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP claimed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO claimed